Trial intelligence / Profile preview

Valproic Acid + Chemoradiation in Locally Advanced HNSCC

NCT01695122Phase 2Completed

Sponsor
Instituto do Câncer do Estado de São Paulo
Start
Sep 2012
Primary completion
Nov 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of valproic acid in head and neck squamous cell carcinoma (HNSCC), sponsored by Instituto do Câncer do Estado de São Paulo. Primary endpoint: Response Rate. Started Sep 2012; status: completed.

02

Drugs

valproic acid
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT01695122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01695122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call